5084 Outer membrane meander beta-barrels
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Lipids and lipid-like molecules | 40 | 12.4 | 3.22× | q < 0.0001 | |
| Homogeneous metal compounds | 62 | 54.7 | 1.13× | q = 0.25 | |
| Organic oxygen compounds | 24 | 22.2 | 1.08× | q = 0.71 | |
| Organic acids and derivatives | 12 | 17.2 | 0.70× | q = 0.26 | |
| Homogeneous non-metal compounds | 12 | 24.0 | 0.50× | q = 0.01 | |
| Benzenoids | 3 | 8.2 | 0.37× | q = 0.10 | |
| Organoheterocyclic compounds | 6 | 17.2 | 0.35× | q = 4.9e-3 | |
| Nucleosides, nucleotides, and analogues | 5 | 30.8 | 0.16× | q < 0.0001 | |
| Hydrocarbons | 15 | 0.8 | 19× | not tested | |
| Organosulfur compounds | 4 | 2.3 | 1.75× | not tested | |
| Phenylpropanoids and polyketides | 4 | 2.3 | 1.73× | not tested | |
| Organic nitrogen compounds | 4 | 3.6 | 1.13× | not tested | |
| Mixed metal/non-metal compounds | 1 | 2.3 | 0.43× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03426 | DGD | Digalactosyl Diacyl Glycerol (Dgdg) | 89 |
| DB04450 | HTG | Heptyl 1-Thiohexopyranoside | 27 |
| DB02767 | FTT | (R)-3-hydroxytetradecanoic acid | 18 |
| DB08249 | N8E | 3,6,9,12,15-PENTAOXATRICOSAN-1-OL | 18 |
| DB08231 | MYR | Myristic acid | 12 |
| DB03193 | STE | Stearic acid | 11 |
| DB02415 | OES | N-Octyl-2-Hydroxyethyl Sulfoxide | 9 |
| DB00141 | NAG | N-Acetylglucosamine | 6 |
| DB03017 | DAO | Lauric acid | 6 |
| DB03548 | KDO | 3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid | 6 |
| DB03556 | PE5 | 2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400 | 6 |
| DB00115 | CNC | Cyanocobalamin | 5 |
| DB18267 | HEM | Ferroheme | 5 |
| DB00171 | ATP | ATP | 4 |
| DB00254 | DXT | Doxycycline | 4 |
| DB02130 | VNL | Vanillic acid | 4 |
| DB03574 | FCI | Ferricrocin-iron | 4 |
| DB08217 | MTN | S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate | 4 |
| DB00142 | GLU | Glutamic acid | 3 |
| DB00415 | AIC | Ampicillin | 3 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CAmetal | CALCIUM ION | 195 |
| DGD | DIGALACTOSYL DIACYL GLYCEROL (DGDG) | 103 |
| NAmetal | SODIUM ION | 87 |
| HTG | heptyl 1-thio-beta-D-glucopyranoside | 84 |
| MGmetal | MAGNESIUM ION | 77 |
| LMG | 1,2-DISTEAROYL-MONOGALACTOSYL-DIGLYCERIDE | 42 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 28 |
| OCT | N-OCTANE | 23 |
| CL | CHLORIDE ION | 21 |
| ZNmetal | ZINC ION | 19 |
| FEmetal | FE (III) ION | 18 |
| FTT | 3-HYDROXY-TETRADECANOIC ACID | 18 |
| N8E | 3,6,9,12,15-PENTAOXATRICOSAN-1-OL | 18 |
| CUmetal | COPPER (II) ION | 16 |
| Kmetal | POTASSIUM ION | 15 |
| MC3 | 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE | 14 |
| LImetal | LITHIUM ION | 12 |
| MYR | MYRISTIC ACID | 12 |
| D12 | DODECANE | 11 |
| HEX | HEXANE | 11 |